MedPath

Clinical study to assess the preventive role of Ayurvedic interventions and Yogic practices in Pre-Diabetic Patients.

Phase 2
Conditions
Health Condition 1: E109- Type 1 diabetes mellitus without complications
Registration Number
CTRI/2023/07/055265
Lead Sponsor
Faculty Of Ayurveda Banaras Hindu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of both sex with BMI - 25- 34.9 kg/m 2

2.Family history of diabetes,HTN, Dyslipidemia.

3. fasting glucose level - 100-125mg/dl

P.P blood sugar- 140-199mg /dl

4.glucose tolerance between 140 and 199mg /dl

5.patients with poorvaropa of prameha

Exclusion Criteria

1.Age >60years

2.diagosed with type 2 diabetes mellitus (fasting glucose >126mg /dl.,P.P > 126mg /dl,HbA1c >7 with or without complications.

3.patient currently using oral hypoglycemic agents ,those reporting prior use of medication to treat diabetes mellitus(except gestational diabetes).

4.patients with symptoms of kidney failure ( microalbuminaria,serum creatinine >2 mg /dl ) or on renal dialysis,reported having received any medication for D.m

5.Tyoe 1 D.M (IDDM) associated with or without complications.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in weight <br/ ><br>Decrease in fatigue <br/ ><br>Decrease in polyuria <br/ ><br>Decrease in polyphagia <br/ ><br>Decrease in polydypsia <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 12 weeks <br/ ><br> <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Decrease in fasting blood sugar <br/ ><br>Post - Prandial blood sugar <br/ ><br>Hb1Ac <br/ ><br>Other laboratory parametersTimepoint: 3months before & after trial
© Copyright 2025. All Rights Reserved by MedPath